Biotech IPOs gone missing

I use the USAToday as a bellweather for public information.  By the time they get a story out, it should be in the public conciousness.
 
 
Take a look at the companies that are attracting attention.  These are the ones with sales.  These are the ones with revenue, and could either blow things out with the protection of a major biotech, or an infusion of capital via the public markets.
 
The ones that are long term research, well they're going to have trouble.
 
Lots of trouble.
 

Copyright 2010
Jean-Luc Park
All rights reserved